A large-scale COVID-19 infection survey

It’s almost certain that COVID-19 cases across the nation have been vastly undercounted, since people with few to no symptoms—who may be infected but have immunity—are rarely tested. The University of California, Irvine is partnering with the Orange County Health Care Agency to participate in a rigorous, large-scale, population-based study that will generate a more accurate estimate of the true […]

» Read more

Mental health during lockdown: Five small things you can do to boost your mood

Mental health takes into account how you are feeling in the present moment. Noticed a bit of a bad mood? Nutritionist Tracy Breuning has five steps to lighten the load. Boost serotonin Breuning begins: “Feel-good neurotransmitter serotonin is manufactured in the gut. “Support your gut flora diversity with prebiotic foods such as bananas, apples, oats, asparagus, onions, garlic and leeks.” […]

» Read more

74% of people are worried social distancing will not be followed as lockdown is eased

Nearly eight in 10 people are worried about COVID-19 infections rising and people not adhering to social distancing as lockdown is eased, according to UCL’s COVID-19 study. The study, launched in the week before the lockdown, is the UK’s largest on adult wellbeing and mental health during the coronavirus epidemic and has over 90,000 participants who report their feelings about […]

» Read more

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

A clinical trial has begun to evaluate whether the malaria drug hydroxychloroquine, given together with the antibiotic azithromycin, can prevent hospitalization and death from coronavirus disease 2019 (COVID-19). The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is sponsoring the trial, which is being conducted by the NIAID-funded AIDS Clinical Trials Group (ACTG). […]

» Read more

Skilled partners in the conduct of HIV prevention trials join COVID-19 response

The NIH-funded HIV Vaccine Trials Network (HVTN) and HIV Prevention Trials Network (HPTN) have initiated their first clinical trial in response to COVID-19. The study, called HVTN 405/HPTN 1901, is underway at clinical trial sites across North and South America and will describe immune responses in study participants with a history of infection with SARS-CoV-2, the virus that causes COVID-19. […]

» Read more
1 1,249 1,250 1,251 1,252 1,253 1,330